ClinicalTrials.gov
ClinicalTrials.gov Menu

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01076530
Recruitment Status : Completed
First Posted : February 26, 2010
Last Update Posted : May 3, 2013
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)